Allogene Therapeutics (ALLO) Times Interest Earned (2018 - 2026)
Allogene Therapeutics recorded quarterly Times Interest Earned of -$153.64 in Q1 2026, down 13.41% quarter-over-quarter from -$135.48 in Q4 2025, and up 64.65% year-over-year from -$93.31 in Q1 2025.
Allogene Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$153.64 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 64.65% year-over-year to -$153.64; the TTM figure through Mar 2026 stood at -$155.28 (up 80.89% YoY), while the FY2025 annual figure was -$194.71, up 87.1% from the prior year.
- Times Interest Earned came in at -$153.64 for Q1 2026 at Allogene Therapeutics, down from -$135.48 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$130.53 in Q3 2025 to a low of -$746.79 in Q4 2024.
- A 3-year average of -$361.54 and a median of -$212.01 in 2025 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned surged 81.86% in 2025 and soared 64.65% in 2026, its largest moves.
- Allogene Therapeutics' Times Interest Earned stood at -$746.79 in 2024, then soared by 81.86% to -$135.48 in 2025, then decreased by 13.41% to -$153.64 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$153.64, -$135.48, and -$130.53 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.88 |
| 10 | Allogene Therapeutics | 521.43 Mn | 521.43 Mn | - | -153.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -153.64 |
| Dec 31, 2025 | -135.48 |
| Sep 30, 2025 | -130.53 |
| Jun 30, 2025 | -212.01 |
| Mar 31, 2025 | -434.61 |
| Dec 31, 2024 | -746.79 |
| Sep 30, 2024 | -717.74 |
| Sep 30, 2018 | -6.61 |